Sputnik V vaccine has 91.6% efficacy against symptomatic Covid, Russian trial suggests

Read Time:20 Second

Preliminary findings based on analysis of data from more than 20,000 participants

Russia’s Sputnik V vaccine has 91.6% efficacy against symptomatic coronavirus, interim trial results have suggested.

The preliminary findings are based on analysis of data from more than 20,000, mostly white, adults, three-quarters of whom received the vaccine. The remainder received a placebo.

Continue reading… Source: The Guardian

0 0
Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleppy
Sleppy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *